查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1608068

植入式心臟整流去颤器市场：按植入部位、产品和最终用户划分 - 2025-2030 年全球预测

Implantable Cardioverter Defibrillators Market by Implantation Location, Product, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年植入式心臟整流去颤器市值为45亿美元，预计到2024年将达到47.3亿美元，复合年增长率为5.91%，预计到2030年将达到67.3亿美元。

植入式心臟整流去颤器(ICD) 是一种旨在检测和治疗危及生命的心律不整的设备，为心臟麻痹高风险患者提供重要的干预措施。由于老化、生活方式改变和遗传倾向等因素，全世界心血管疾病的盛行率不断增加，因此需要 ICD。 ICD 是紧急干预领域的先驱，它可以持续监测心律，并在必要时进行电击以使其恢復正常。该市场的主要最终用户包括医院、诊所和门诊手术中心，在这些地方，快速获得这些挽救生命的治疗至关重要。这个市场受到人们对心血管健康意识的提高以及使 ICD 更加高效和患者友好的技术进步的显着影响。整合人工智慧以提高设备效率、小型化以提高患者舒适度以及延长电池寿命代表着潜在的成长机会。然而，市场面临挑战，ICD 价格高昂和严格的监管合规阻碍了新创新的快速推出。此外，对设备併发症的怀疑可能会影响患者的接受度。为了应对这些挑战，建议专注于具有成本效益的製造方法并确保严格的安全标准。潜在的创新领域包括研究用于设备组件的生物分解性材料以及增强预测演算法以提高心律不整检测的准确性。 ICD 市场竞争激烈且发展迅速，需要持续的技术创新和监管合规性。强调与医疗保健提供者的合作、加深对现实世界的洞察以及客製化解决方案以满足不同的世界和需求，可以让您在这个动态的环境中获得优势。儘管存在这些障碍，ICD 市场仍具有巨大的成长和创新潜力，预计将大大有助于改善患者的治疗效果，特别是在心臟治疗方面。

主要市场统计
基准年[2023] 45亿美元
预测年份 [2024] 47.3亿美元
预测年份 [2030] 67.3亿美元
复合年增长率（%） 5.91%

市场动态：快速发展的植入式心臟整流去颤器市场的关键市场洞察

供需的动态交互作用正在改变植入式心臟整流去颤器市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 随着患有心血管疾病的人口老化，人们对 ICD 益处的认识不断提高。
    • 有效治疗心律不整、心室颤动、心室心搏过速所引起的心臟麻痹
    • 世界各地有关 ICD 的培训和宣传计划数量增加
  • 市场限制因素
    • 技术问题导致大量产品召回
  • 市场机会
    • 新技术的出现以及 S-ICD 和 ICD 的采用增加
    • 新兴国家对 ICD 的需求不断增长
  • 市场挑战
    • 某些国家对突发心臟病的认知较低

波特五力：驾驭植入式心臟整流去颤器市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解外部对植入式心臟整流去颤器市场的影响

外部宏观环境因素在塑造植入式心臟整流去颤器市场的性能动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解植入式心臟整流去颤器市场的竞争格局

对植入式心臟整流去颤器市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位植入式心臟整流去颤器市场供应商的绩效评估

FPNV定位矩阵是评估植入式心臟整流去颤器市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘植入式心臟整流去颤器市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，植入式心臟整流去颤器市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 患有心血管疾病的老化人口不断增加，人们对 ICD 装置益处的认识不断增强
      • 有效治疗心律不整、心室颤动、心室心搏过速所引起的心臟麻痹。
      • ICD 培训和意识计划在全球范围内增加
    • 抑制因素
      • 经常导致产品召回的相关技术问题
    • 机会
      • 新技术的出现以及 S-ICD 和 ICD 的采用增加
      • 新兴国家对 ICD 的需求不断增加
    • 任务
      • 有些国家对突发心臟病的认知有限
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章植入式心臟整流去颤器

  • 皮下植入式心臟整流去颤器
  • 植入式心臟整流去颤器

第七章植入式心臟整流去颤器市场：副产品

  • 双心室/心臟再同步治疗心臟去颤器
  • 双腔室ICD
  • 单腔ICD

第八章植入式心臟整流去颤器市场：依最终用户分类

  • 门诊治疗室
  • 心臟中心
  • 电生理实验室
  • 居家照护环境
  • 医院/诊所

第九章美洲植入式心臟整流去颤器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太植入式心臟整流去颤器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲植入式心臟整流去颤器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AtaCor Medical, Inc.
  • BIOTRONIK SE & Co KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova plc
  • Medtronic plc
  • MicroPort Scientific Corporation
Product Code: MRR-037F3DB25943

The Implantable Cardioverter Defibrillators Market was valued at USD 4.50 billion in 2023, expected to reach USD 4.73 billion in 2024, and is projected to grow at a CAGR of 5.91%, to USD 6.73 billion by 2030.

Implantable Cardioverter Defibrillators (ICDs) are devices designed to detect and treat life-threatening arrhythmias, providing crucial interventions for patients with high risks of sudden cardiac arrest. Their necessity stems from the increasing prevalence of cardiovascular diseases globally due to factors such as aging populations, lifestyle changes, and genetic predisposition. ICDs are vanguards in emergency interventions, continuously monitoring heart rhythms and administering shocks to restore normalcy when needed. Key end-users in this market include hospitals, clinics, and ambulatory surgical centers, where quick access to such life-saving interventions is paramount. The market is significantly influenced by advancements in technology, which have made ICDs more efficient and patient-friendly, alongside a rising awareness of cardiovascular health. The integration of Artificial Intelligence in enhancing device efficacy, miniaturization for patient comfort, and battery life improvements represent potential opportunities for growth. However, the market faces challenges, including high costs of ICDs and strict regulatory compliances that can hinder the swift introduction of new innovations. Furthermore, skepticism about device complications can impact patient acceptance. To address these challenges, focusing on cost-effective production methods and ensuring rigorous safety standards are recommended. Potential areas for innovation include research into biodegradable materials for device components and enhancing the predictive algorithms for better arrhythmia detection accuracy. The nature of the ICD market is highly competitive and fast-evolving, necessitating continuous innovation and regulatory navigation. Emphasizing collaborations with healthcare providers for better real-world insights and tailoring solutions to meet diverse global needs could provide an edge in this dynamic landscape. Despite the hurdles, the ICD market presents substantial growth and innovation avenues, especially towards contributing significantly to enhancing patient outcomes in cardiac care.

KEY MARKET STATISTICS
Base Year [2023] USD 4.50 billion
Estimated Year [2024] USD 4.73 billion
Forecast Year [2030] USD 6.73 billion
CAGR (%) 5.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Implantable Cardioverter Defibrillators Market

The Implantable Cardioverter Defibrillators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing aging population for cardiovascular diseases and rising awareness about advantages of ICD devices
    • Effective in treating sudden cardiac arrest caused due to cardiac arrhythmias, ventricular fibrillation and pulseless ventricular tachycardia
    • Increasing number of training and awareness programs across the globe for ICDs
  • Market Restraints
    • Associated technical issues with noticeable incidence of product recall
  • Market Opportunities
    • Emergence of new technologies and an increase in adoption of S-ICDs and ICDs
    • Growing demand of ICDs from emerging economies
  • Market Challenges
    • Limited awareness about sudden cardiac attack in the certain countries

Porter's Five Forces: A Strategic Tool for Navigating the Implantable Cardioverter Defibrillators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Implantable Cardioverter Defibrillators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Implantable Cardioverter Defibrillators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Implantable Cardioverter Defibrillators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Implantable Cardioverter Defibrillators Market

A detailed market share analysis in the Implantable Cardioverter Defibrillators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Implantable Cardioverter Defibrillators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Implantable Cardioverter Defibrillators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Implantable Cardioverter Defibrillators Market

A strategic analysis of the Implantable Cardioverter Defibrillators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Implantable Cardioverter Defibrillators Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AtaCor Medical, Inc., BIOTRONIK SE & Co KG, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova plc, Medtronic plc, and MicroPort Scientific Corporation.

Market Segmentation & Coverage

This research report categorizes the Implantable Cardioverter Defibrillators Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Implantation Location, market is studied across Subcutaneous Implantable Cardioverter Defibrillator and Transvenous Implantable Cardioverter Defibrillator.
  • Based on Product, market is studied across Biventricular/Cardiac Resynchronization Therapy Defibrillators, Dual-Chamber ICD, and Single-Chamber ICD.
  • Based on End User, market is studied across Ambulatory Care Unit, Cardiac Center, Electrophysiology Laboratory, Home Care Setting, and Hospital & Clinic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging population for cardiovascular diseases and rising awareness about advantages of ICD devices
      • 5.1.1.2. Effective in treating sudden cardiac arrest caused due to cardiac arrhythmias, ventricular fibrillation and pulseless ventricular tachycardia
      • 5.1.1.3. Increasing number of training and awareness programs across the globe for ICDs
    • 5.1.2. Restraints
      • 5.1.2.1. Associated technical issues with noticeable incidence of product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of new technologies and an increase in adoption of S-ICDs and ICDs
      • 5.1.3.2. Growing demand of ICDs from emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness about sudden cardiac attack in the certain countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Implantable Cardioverter Defibrillators Market, by Implantation Location

  • 6.1. Introduction
  • 6.2. Subcutaneous Implantable Cardioverter Defibrillator
  • 6.3. Transvenous Implantable Cardioverter Defibrillator

7. Implantable Cardioverter Defibrillators Market, by Product

  • 7.1. Introduction
  • 7.2. Biventricular/Cardiac Resynchronization Therapy Defibrillators
  • 7.3. Dual-Chamber ICD
  • 7.4. Single-Chamber ICD

8. Implantable Cardioverter Defibrillators Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Unit
  • 8.3. Cardiac Center
  • 8.4. Electrophysiology Laboratory
  • 8.5. Home Care Setting
  • 8.6. Hospital & Clinic

9. Americas Implantable Cardioverter Defibrillators Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Implantable Cardioverter Defibrillators Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Implantable Cardioverter Defibrillators Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AtaCor Medical, Inc.
  • 3. BIOTRONIK SE & Co KG
  • 4. Boston Scientific Corporation
  • 5. Koninklijke Philips N.V.
  • 6. LivaNova plc
  • 7. Medtronic plc
  • 8. MicroPort Scientific Corporation

LIST OF FIGURES

  • FIGURE 1. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET RESEARCH PROCESS
  • FIGURE 2. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET DYNAMICS
  • TABLE 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DUAL-CHAMBER ICD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SINGLE-CHAMBER ICD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY CARE UNIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY ELECTROPHYSIOLOGY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023